Supernus Pharmaceuticals Inc (NASDAQ:SUPN)
| 35.54 Delayed Data As of 3:59pm ET |  +1.68 / +4.96%Today’s Change | 23.15 Today|||52-Week Range 35.54 | +21.88% Year-to-Date |
Latest SUPN News | Press Releases
| Best Momentum Stocks to Buy for August 8th Aug 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 33.86 |
| Today’s open | 33.99 |
| Day’s range | 33.99 - 35.54 |
| Volume | 16,095 |
| Average volume (3 months) | 400,465 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 08/19/2022
Growth & Valuation
| Earnings growth (last year) | -58.30% |
| Earnings growth (this year) | +84.01% |
| Earnings growth (next 5 years) | -22.60% |
| Revenue growth (last year) | +11.41% |
| P/E ratio | 35.2 |
| Price/Sales | 2.73 |
| Price/Book | 2.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IRWDIronwood Pharmaceuti... | +0.09 | +0.76% |
| --Microalliance Group ... | 0.00 | 0.00% |
| ---- | ||
| LGNDLigand Pharmaceutica... | -1.41 | -1.35% |
Data as of 4:00pm ET, 08/19/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $579.8M |
| Annual profit (last year) | $53.4M |
| Net profit margin | 9.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
